Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration (multiple letters) [1]

American Journal of Ophthalmology

Volumn 133, Issue 6, 2002, Pages 857-859

  Jonas, Jost B ^a   Bressler, Neil M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

DECISION MAKING; FLUORESCENCE ANGIOGRAPHY; HUMAN; LETTER; MYOPIA; OPTIC DISK; PRIORITY JOURNAL; REFRACTION ERROR; RETINA MACULA AGE RELATED DEGENERATION; RISK BENEFIT ANALYSIS; SUBRETINAL NEOVASCULARIZATION; TECHNIQUE; VISUAL ACUITY;

EID: 0036264201     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9394(02)01423-x     Document Type: Letter

References (4)

1. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials-TAP Report 1
2. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin; one-year results of a randomized clinical trial-VIP Report 1
3. Subfoveal neovascular lesions in age-related macular degeneration; guidelines for evaluation and treatment in the Macular Photocoagulation Study
4. The effect of axial length on laser spot size and laser irradiance